X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8199) 8199
Newsletter (714) 714
Book Review (408) 408
Publication (203) 203
Magazine Article (26) 26
Conference Proceeding (20) 20
Dissertation (20) 20
Book Chapter (17) 17
Newspaper Article (13) 13
Web Resource (6) 6
Data Set (3) 3
Government Document (3) 3
Reference (3) 3
Report (3) 3
Book / eBook (1) 1
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6020) 6020
atenolol (4835) 4835
humans (4714) 4714
male (3985) 3985
female (2979) 2979
middle aged (2454) 2454
atenolol - therapeutic use (2408) 2408
adult (2162) 2162
hypertension - drug therapy (2067) 2067
atenolol - pharmacology (1859) 1859
aged (1553) 1553
hypertension (1543) 1543
blood pressure - drug effects (1519) 1519
animals (1419) 1419
pharmacology & pharmacy (1250) 1250
heart rate - drug effects (1204) 1204
double-blind method (1117) 1117
adrenergic beta-antagonists - therapeutic use (1050) 1050
antihypertensive agents - therapeutic use (945) 945
abridged index medicus (918) 918
adrenergic beta-antagonists - pharmacology (864) 864
atenolol - administration & dosage (826) 826
cardiac & cardiovascular systems (826) 826
rats (777) 777
hypertension - physiopathology (752) 752
atenolol - adverse effects (664) 664
propranolol (650) 650
peripheral vascular disease (630) 630
drugs (629) 629
drug therapy, combination (610) 610
blood pressure (560) 560
treatment outcome (559) 559
time factors (538) 538
research (534) 534
propranolol - pharmacology (515) 515
beta-blockers (492) 492
clinical trials as topic (489) 489
blood-pressure (458) 458
metoprolol (441) 441
hypertension - complications (423) 423
medicine, general & internal (423) 423
propanolamines - pharmacology (418) 418
dose-response relationship, drug (411) 411
electrocardiography (405) 405
analysis (404) 404
mortality (395) 395
drug therapy (382) 382
propanolamines - therapeutic use (374) 374
hemodynamics - drug effects (369) 369
risk factors (368) 368
adolescent (335) 335
random allocation (332) 332
heart rate (326) 326
adrenergic beta-antagonists - administration & dosage (301) 301
chemistry, analytical (301) 301
reports (293) 293
follow-up studies (274) 274
exercise test (272) 272
prospective studies (268) 268
adrenergic beta-antagonists - adverse effects (266) 266
antihypertensive agents - pharmacology (264) 264
angina pectoris - drug therapy (259) 259
antihypertensive agents - adverse effects (255) 255
isoproterenol - pharmacology (255) 255
antihypertensive agents - administration & dosage (253) 253
aged, 80 and over (251) 251
losartan - therapeutic use (247) 247
pharmacokinetics (241) 241
dogs (235) 235
kinetics (234) 234
care and treatment (231) 231
universities and colleges (231) 231
atenolol - blood (229) 229
therapy (228) 228
angiotensin-converting enzyme inhibitors - therapeutic use (226) 226
atenolol - pharmacokinetics (225) 225
nifedipine (222) 222
risk (221) 221
randomized controlled trials as topic (220) 220
losartan (219) 219
propranolol - therapeutic use (218) 218
metoprolol - therapeutic use (214) 214
prevention (210) 210
nebivolol (209) 209
in vitro techniques (207) 207
medical research (207) 207
rats, wistar (207) 207
administration, oral (205) 205
hydrochlorothiazide (202) 202
pharmaceuticals (201) 201
calcium channel blockers - therapeutic use (199) 199
atenolol - chemistry (195) 195
exercise (194) 194
double-blind (193) 193
drug interactions (193) 193
heart - drug effects (190) 190
cardiovascular system (188) 188
hypertension - blood (188) 188
echocardiography (187) 187
blood pressure - physiology (186) 186
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8208) 8208
German (174) 174
Russian (160) 160
French (103) 103
Italian (97) 97
Spanish (71) 71
Portuguese (35) 35
Chinese (30) 30
Polish (28) 28
Japanese (16) 16
Korean (16) 16
Danish (14) 14
Swedish (14) 14
Norwegian (10) 10
Dutch (9) 9
Czech (5) 5
Serbian (5) 5
Turkish (4) 4
Hungarian (3) 3
Romanian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Hebrew (2) 2
Ukrainian (2) 2
Arabic (1) 1
Croatian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Electroanalytical Chemistry, ISSN 1572-6657, 03/2016, Volume 765, p. 30
BiVO.sub.4-Bi.sub.2O.sub.3 composite particles were synthesized by combustion synthesis (SCS) and immobilized on the ITO surface by layer-by-layer (LbL)... 
Atenolol
Journal Article
Journal of Pharmacological and Toxicological Methods, ISSN 1056-8719, 09/2009, Volume 60, Issue 2, pp. 224 - 225
Journal Article
Journal Article
Environmental Science and Pollution Research, ISSN 0944-1344, 01/2018, Volume 25, Issue 1, p. 693
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11356-017-0256-z Efficient... 
Analysis | Atenolol
Journal Article
Talanta, ISSN 0039-9140, 06/2006, Volume 69, Issue 4, p. 932
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 08/2009, Volume 30, Issue 8, p. 714
Nous rapportons l'observation d'une femme de 53 ans presentant une hyperkaliemie a 6,3mmol/l rattachee a la prise d'atenolol. Le diagnostic d'hyperkaliemie lie... 
Atenolol
Journal Article
Water Research, ISSN 0043-1354, 01/2011, Volume 45, Issue 3, pp. 1432 - 1442
The occurrence of fifty-five pharmaceuticals, hormones and metabolites in raw waters used for drinking water production and their removal through a drinking... 
Drinking water | Chlorination | Ozonation | GAC | Hormones | Tap water | Pharmaceuticals | PERSONAL CARE PRODUCTS | POLAR DRUG RESIDUES | AQUATIC ENVIRONMENT | WATER RESOURCES | SURFACE-WATER | TANDEM MASS-SPECTROMETRY | ENVIRONMENTAL SCIENCES | ENGINEERING, ENVIRONMENTAL | WASTE-WATER | ENDOCRINE DISRUPTING COMPOUNDS | ORGANIC-COMPOUNDS | MULTI-RESIDUE ANALYSIS | NATIONAL RECONNAISSANCE | Pharmaceutical Preparations - isolation & purification | Sotalol - isolation & purification | Sotalol - chemistry | Phenytoin - isolation & purification | Carbamazepine - chemistry | Phenytoin - chemistry | Water Pollutants, Chemical - isolation & purification | Hormones - analysis | Atenolol - analysis | Carbamazepine - analogs & derivatives | Carbamazepine - analysis | Hormones - isolation & purification | Ozone - chemistry | Hydrochlorothiazide - chemistry | Water Pollutants, Chemical - chemistry | Hormones - chemistry | Water Pollutants, Chemical - analysis | Sotalol - analysis | Atenolol - chemistry | Pharmaceutical Preparations - chemistry | Hydrochlorothiazide - isolation & purification | Phenytoin - analysis | Atenolol - isolation & purification | Hydrochlorothiazide - analysis | Carbamazepine - isolation & purification | Pharmaceutical Preparations - analysis | Water Purification - methods | Water Supply - analysis | Ozonization | Metabolites | Atenolol | Phenytoin | Carbamazepine | Drugs | Filtration | Sand | Raw | Intakes | Index Medicus
Journal Article
1985, Thieme Copythek., ISBN 3136689011, 157
Book
Chemosphere, ISSN 0045-6535, 02/2019, Volume 216, p. 248
BiOCl@Fe.sub.3O.sub.4 photocatalyst was synthesized to activate peroxymonosulfate (PMS) for atenolol (ATL) degradation under simulated sunlight irradiation in... 
Photolysis | Carbonates | Atenolol
Journal Article
Chemical Engineering Journal, ISSN 1385-8947, 08/2018, Volume 345, p. 669
This work approaches the preparation of KOH and K.sub.2CO.sub.3 activated carbons from apple tree small branches char with activation yields around 40%, and... 
Adsorption | Analysis | Atenolol
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Index Medicus | Abridged Index Medicus | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
Separation and Purification Technology, ISSN 1383-5866, 10/2013, Volume 118, p. 879
Display Omitted 
Atenolol | Chromatography
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 22, pp. 2061 - 2071
Journal Article
10/2011
Objectives: To study the effect of nebivolol 5 mg once daily versus (S)-atenolol 25 mg once daily in patients with essential hypertension. Materials and... 
Essential hypertension | nebivolol | (S)-atenolol
Web Resource
The Science of the Total Environment, ISSN 0048-9697, 02/2017, Volume 579, p. 1769
The identification of toxic components in cocktail mixtures of pollutants, their metabolites and transformation products (TPs) generated from environmental and... 
Metoprolol | Photolysis | Atenolol | Cells
Journal Article
Tetrahedron, ISSN 0040-4020, 11/2016, Volume 72, Issue 46, p. 7288
Both enantiomers of 4-(3-chloro-2-hydroxypropoxy)phenyl)acetamide has been synthesized in 98.5-99% enantiomeric excess by use of lipase B from Candida... 
Enzymes | Amides | Atenolol | Enantiomers
Journal Article
The Lancet, ISSN 0140-6736, 2004, Volume 364, Issue 9446, pp. 1684 - 1689
Journal Article
Journal Article